Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 49,531 shares changing hands.
Evofem Biosciences Stock Performance
The firm has a market cap of $1.02 million, a price-to-earnings ratio of -0.01 and a beta of -0.87. The firm’s 50 day moving average is $0.01 and its 200-day moving average is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- What is diluted earnings per share (Diluted EPS)?
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
